Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of the study is to compare safety and efficacy of a single dose of empegfilgrastim and daily dosing of filgrastim for prevention of neutropenia in patients receiving AT (docetaxel 75 mg/m2 + doxorubicin 50 mg/m2).
Epistemonikos ID: 79a46cf71224d4d1143053b756f487731c681cf0
First added on: May 11, 2024